These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14599359)

  • 1. Phage display of functional human TNF-alpha converting enzyme catalytic domain: a rapid method for the production of stabilized proteolytic proteins for assay development and high-throughput screening.
    Chen Y; Diener K; Patel IR; Kawooya JK; Martin GA; Yamdagni P; Zhang X; Sandrasalphaa A; Sahasrabudhe S; Busch SJ
    J Biomol Screen; 2002 Oct; 7(5):433-40. PubMed ID: 14599359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.
    Zhang Y; Xu J; Levin J; Hegen M; Li G; Robertshaw H; Brennan F; Cummons T; Clarke D; Vansell N; Nickerson-Nutter C; Barone D; Mohler K; Black R; Skotnicki J; Gibbons J; Feldmann M; Frost P; Larsen G; Lin LL
    J Pharmacol Exp Ther; 2004 Apr; 309(1):348-55. PubMed ID: 14718605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzyme.
    Lee MH; Verma V; Maskos K; Nath D; Knäuper V; Dodds P; Amour A; Murphy G
    Biochem J; 2002 May; 364(Pt 1):227-34. PubMed ID: 11988096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate specificity and novel selective inhibitors of TNF-alpha converting enzyme (TACE) from two-dimensional substrate mapping.
    Lambert MH; Blackburn RK; Seaton TD; Kassel DB; Kinder DS; Leesnitzer MA; Bickett DM; Warner JR; Andersen MW; Badiang JG; Cowan DJ; Gaul MD; Petrov KG; Rabinowitz MH; Wiethe RW; Becherer JD; McDougald DL; Musso DL; Andrews RC; Moss ML
    Comb Chem High Throughput Screen; 2005 Jun; 8(4):327-39. PubMed ID: 16101009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening of TACE peptide inhibitors from a phage display random 15-peptide library by recombinant TACE ecotodomain].
    Huang W; Li LB; Han L; Zhang H; Yang YZ
    Sheng Wu Gong Cheng Xue Bao; 2005 Jan; 21(1):30-5. PubMed ID: 15859325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases.
    Hiraoka Y; Yoshida K; Ohno M; Matsuoka T; Kita T; Nishi E
    Biochem Biophys Res Commun; 2008 May; 370(1):154-8. PubMed ID: 18355445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alpha.
    Patel IR; Attur MG; Patel RN; Stuchin SA; Abagyan RA; Abramson SB; Amin AR
    J Immunol; 1998 May; 160(9):4570-9. PubMed ID: 9574564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the tumor necrosis factor-alpha-converting enzyme by its pro domain.
    Gonzales PE; Solomon A; Miller AB; Leesnitzer MA; Sagi I; Milla ME
    J Biol Chem; 2004 Jul; 279(30):31638-45. PubMed ID: 15100227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of TACE peptide inhibitors from phage display peptide library.
    Huang W; Li L; Han L; Yang Y
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(5):473-6. PubMed ID: 16463648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pronounced diversity in electronic and chemical properties between the catalytic zinc sites of tumor necrosis factor-alpha-converting enzyme and matrix metalloproteinases despite their high structural similarity.
    Solomon A; Rosenblum G; Gonzales PE; Leonard JD; Mobashery S; Milla ME; Sagi I
    J Biol Chem; 2004 Jul; 279(30):31646-54. PubMed ID: 15102849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme.
    Reddy P; Slack JL; Davis R; Cerretti DP; Kozlosky CJ; Blanton RA; Shows D; Peschon JJ; Black RA
    J Biol Chem; 2000 May; 275(19):14608-14. PubMed ID: 10799547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and purification of correctly processed, active human TACE catalytic domain in Saccharomyces cerevisiae.
    Clarke HR; Wolfson MF; Rauch CT; Castner BJ; Huang CP; Gerhart MJ; Johnson RS; Cerretti DP; Paxton RJ; Price VL; Black RA
    Protein Expr Purif; 1998 Jun; 13(1):104-10. PubMed ID: 9631522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple metalloproteinases process protransforming growth factor-alpha (proTGF-alpha).
    Hinkle CL; Mohan MJ; Lin P; Yeung N; Rasmussen F; Milla ME; Moss ML
    Biochemistry; 2003 Feb; 42(7):2127-36. PubMed ID: 12590602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17).
    Qiu Z; Yan M; Li Q; Liu D; Van den Steen PE; Wang M; Opdenakker G; Hu J
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):533-40. PubMed ID: 21827363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.
    Amour A; Slocombe PM; Webster A; Butler M; Knight CG; Smith BJ; Stephens PE; Shelley C; Hutton M; Knäuper V; Docherty AJ; Murphy G
    FEBS Lett; 1998 Sep; 435(1):39-44. PubMed ID: 9755855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species mediate tumor necrosis factor alpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate.
    Zhang Z; Oliver P; Lancaster JR; Schwarzenberger PO; Joshi MS; Cork J; Kolls JK
    FASEB J; 2001 Feb; 15(2):303-5. PubMed ID: 11156944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity.
    Mohan MJ; Seaton T; Mitchell J; Howe A; Blackburn K; Burkhart W; Moyer M; Patel I; Waitt GM; Becherer JD; Moss ML; Milla ME
    Biochemistry; 2002 Jul; 41(30):9462-9. PubMed ID: 12135369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific sequence elements are required for the expression of functional tumor necrosis factor-alpha-converting enzyme (TACE).
    Milla ME; Leesnitzer MA; Moss ML; Clay WC; Carter HL; Miller AB; Su JL; Lambert MH; Willard DH; Sheeley DM; Kost TA; Burkhart W; Moyer M; Blackburn RK; Pahel GL; Mitchell JL; Hoffman CR; Becherer JD
    J Biol Chem; 1999 Oct; 274(43):30563-70. PubMed ID: 10521439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease.
    Brynskov J; Foegh P; Pedersen G; Ellervik C; Kirkegaard T; Bingham A; Saermark T
    Gut; 2002 Jul; 51(1):37-43. PubMed ID: 12077089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.
    Canault M; Leroyer AS; Peiretti F; Lesèche G; Tedgui A; Bonardo B; Alessi MC; Boulanger CM; Nalbone G
    Am J Pathol; 2007 Nov; 171(5):1713-23. PubMed ID: 17872973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.